DUBLIN , April 28, 2022 /PRNewswire/ -- The "Medical Oxygen Concentrators Market, by Modality, by Technology, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
Oxygen concentrators are widely used to treat patients with deficient supply of oxygen or who lack adequate amount of oxygen in blood. This device can be operated by being plugged into an energy source or using batteries. Oxygen concentrators are better alternative to oxygen cylinders that are heavy to carry everywhere. Oxygen concentrators can either be fixed devices or portable.
Therefore, these devices can also be used at home. However, a prescription from a registered physician is required to purchase oxygen concentrators. Patients with severe respiratory disorders (asthma, nocturnal hypoxemia, terminal malignancy, and hypoxia) and cardiovascular diseases are prescribed oxygen concentrators. Moreover, oxygen concentrators are widely used in military or in case of disasters where carrying/using oxygen tanks could be risky due to its highly combustible nature. Market Dynamics
The increasing number of surgeries is expected to offer lucrative growth opportunities for players in the global medical oxygen concentrators market. Generally oxygen is provided to patients at the time of surgery to prevent or treat acute hypoxaemia.
For instance, according to Australian Institute of Health and Welfare's Hospitals at a glance 2017-18 report updated in August 2019 , admissions for emergency surgery increased between 2016-2017 and 2017-2018 by 2.9% in public hospitals and by 5.1% in private hospitals in Australia . Key features of the study:
This report provides in-depth analysis of the global medical oxygen concentrators market , and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global medical oxygen concentrators market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Inogen Inc., Invacare Corporation, OxygenToGo, LLC, Koninklijke Philips N.V., ResMed Inc., Drive DeVilbiss Healthcare LLC, Precision Medical, Inc., Besco Medical Co. Ltd., O2 Concepts, LLC, and GCE Group
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global medical oxygen concentrators market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical oxygen concentrators market
Key Topics Covered: 1. Research Objectives and Assumptions
Market Snapshot, By End User
3. Market Dynamics, Regulations, and Trends Analysis
4. Global Medical Oxygen Concentrators Market- Covid-19 Impact Analysis
Supply side and Demand Side Analysis
5. Global Medical Oxygen Concentrators Market, By Modality, 2017 - 2028, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
6. Global Medical Oxygen Concentrators Market, By Technology, 2017 - 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
7. Global Medical Oxygen Concentrators Market, By End User, 2017 - 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
8. Global Medical Oxygen Concentrators Market, By Region, 2017 - 2028, (US$ Mn)
For more information about this report visit https://www.researchandmarkets.com/r/5br4qk
Research and Markets Laura Wood , Senior Manager press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/insights-on-the-medical-oxygen-concentrators-global-market-to-2028---featuring-invacare-resmed-and-precision-medical-among-others-301535689.html
On a bright, promising day for the stock market, with the Dow up 1.5% and the S&P 500 closing 2.4% higher, Ford Motor Company (NYSE: F) stock raced higher than most, advancing an amazing 8.5% through the closing bell. You can thank Morgan Stanley for that. Investors were ebullient in general today, and no doubt that optimism -- after more than a week of nearly nonstop selling -- helped to jump-start Ford stock moving higher.
In my April 28th Real Money column, I wrote a heartfelt letter to Elon Musk imploring him to walk away from Twitter . Musk followed that with a tweet two hours later stating that he "was still committed to the transaction." The threads of Elon's Twitter bid have been laid bare for the past two weeks.
Shares of Boeing (NYSE: BA) joined the rally on Friday morning, trading up more than 6% at one point, only to give up most of those gains as they day went on. Investors got a reminder of the challenges that face Boeing's commercial division, taking the wind out of the shares. It's been a tough run for Boeing, with shares down by more than 60% since the start of 2020.
Feel poorer after the S&P 500's sell-off? Just know it could be worse. Much worse. Investors who piled in some $40 billion firms found out.
Tesla (TSLA) CEO Elon Musk’s early Friday morning tweet proclaiming his $44 billion bid to buy Twitter (TWTR) is on hold may violate laws meant to protect public markets from manipulation, experts say.
Micron could be the cheapest tech stock in the market, based on its price/earnings ratio. Western Digital isn’t far behind.
In this article, we will discuss the 12 best energy stocks for 2022. If you want to skip our detailed analysis of the energy sector which highlights key trends and major players, you can go directly to 5 Best Energy Stocks for 2022. The energy sector has been the biggest contributor to skyrocketing inflation in […]
We've seen this movie before only to watch dip-buyers get fleeced — but money managers are now warming to the idea of a material bounce in stocks.
Billionaire Warren Buffet is one of two people in the top ten richest people in the world who has seen his net worth rise since January, according to the Bloomberg Billionaires Index. The CEO of Berkshire Hathaway ( (BRK.A) - Get Berkshire Hathaway Inc. Class A Report, is ranked number five on the index, which is a daily ranking of the world's richest people. The only other billionaire in the top 10 of the Bloomberg list is Gautam Adani, an Indian infrastructure magnate that owns real estate, commodities and power generation and transmission, whose total net worth is $102 billion and his year-to-date performance is a profit of $25.5 billion.
(Reuters) -Elon Musk tweeted on Friday that his $44-billion cash deal for Twitter Inc was “temporarily on hold” while he waits for the social media company to provide data on the proportion of its fake accounts. Twitter shares initially fell more than 20% in premarket trading, but after Musk, the chief executive of electric car market Tesla Inc, sent a second tweet saying he remained committed to the deal, they regained some ground. The shares were down 9.6% to $40.71 in trading on Friday, a steep discount to the $54.20 per share acquisition price.
(Bloomberg) -- The week is ending on a higher note for Big Tech on hopes a relentless selloff may be nearing exhaustion. But Friday’s rally can’t completely wipe out a sobering signal from Apple Inc. shares. Most Read from BloombergElon Musk Sows Doubt Over His $44 Billion Twitter TakeoverSony PlayStation Staff Fume Over CEO’s Abortion CommentsApple Testing iPhones That Ditch Lightning Ports in Favor of USB-CUkraine Latest: US Senator Delays Aid Vote; Russia Eyes BorderStocks Roar Back at End of
The stock market presents a somewhat confusing picture for now. The main indexes are all steeply down for the year so far – with losses of 16% on the S&P 500 and 25% on the NASDAQ. Drops of this magnitude come with a caveat, however: it’s inevitable that some fundamentally sound stocks are seeing drops in share price just due to the overall market’s downward trend. Indeed, Wall Street’s analysts are seeing plenty, in their words, attractive entry points -- beaten-down stocks that are primed for
Our call of the day from Thomas Kee Jr. is pounding the table over the importance of volatility, but says investors need to not just fear the lows, but embrace the highs.
High-growth profitless stocks bounced big on Friday. A mere short-covering bounce, or the start of more upside?
Berkshire Hathaway is on pace to collect more than $6 billion in dividend income over the next year. Roughly $4.3 billion will come from just five stocks.
The end of the U.S. stock market’s correction is looking a lot closer. It’s encouraging, from a contrarian perspective, that the market timer community in recent days has become extremely pessimistic — as pessimistic, in fact, as it has been at prior market bottoms.
These blue chip stocks can generate steady passive income in even the most challenging environments.
The departing executives said he was asked to leave by the CEO, who "wants to take the team in a different direction."
A cryptocurrency crash has already wiped out $600 billion in digital asset market value over the past week. With the declines in crypto outpacing those in stocks, Bitcoin may actually be a bellwether for capitulation among investors—that point when the market can really find a bottom, according to analyst Barry Bannister at Stifel. “We monitor several factors which we believe will mark the capitulatory low for stocks,” Bannister said in a Wednesday note.
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...